The University of Oxford’s Jenner Institute and Oxford Vaccine Group have been at the forefront of scientific endeavour to develop vaccines for diseases of major global importance for more than 30 years.

Their ChAdOx1 trials are currently assessing whether the vaccine will be effective in combatting COVID-19.